[文献资料]参 考 文 献

Exemestane for breast-cancer prevention in postmenopausal women .Safety and efficacy of the oral PARP inhibitor olaparib（AZD2281）in combination with paclitaxel for the first-or second-line treatment of patients with metastatic triple-negative breast cance ......